Gillian C. Ivers-Read
2016
In 2016, Gillian C. Ivers-Read earned a total compensation of $1.9M as EVP of Technical Operations and Chief Regulatory Officer at Clovis Oncology, a 14% decrease compared to previous year.
Compensation breakdown
| Bonus | $286,443 |
|---|---|
| Salary | $422,300 |
| Stock Awards | $1,214,400 |
| Other | $26,423 |
| Total | $1,949,566 |
Ivers-Read received $1.2M in stock awards, accounting for 62% of the total pay in 2016.
Ivers-Read also received $286.4K in bonus, $422.3K in salary and $26.4K in other compensation.
Rankings
In 2016, Gillian C. Ivers-Read's compensation ranked 4,990th out of 14,075 executives tracked by ExecPay. In other words, Ivers-Read earned more than 64.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,990 out of 14,075 | 65th |
Division Manufacturing | 1,780 out of 5,486 | 68th |
Major group Chemicals And Allied Products | 567 out of 1,900 | 70th |
Industry group Drugs | 423 out of 1,543 | 73rd |
Industry Pharmaceutical Preparations | 338 out of 1,173 | 71st |
Source: SEC filing on April 26, 2017.
Ivers-Read's colleagues
We found five more compensation records of executives who worked with Gillian C. Ivers-Read at Clovis Oncology in 2016.
2016
Lindsey Rolfe
Clovis Oncology
Chief Medical Officer
2016
C Hooks
Clovis Oncology
Senior VP and Chief Commercial Officer
2016
Daniel Muehl
Clovis Oncology
Senior VP of Finance
2016
Patrick Mahaffy
Clovis Oncology
Chief Executive Officer
2016
Erle Mast
Clovis Oncology
Chief Financial Officer
News
Clovis Oncology CEO Patrick Mahaffy's 2021 pay slips 18% to $2.6M
April 27, 2022
Clovis Oncology CEO Patrick Mahaffy's 2020 pay falls 53% to $3.2M
April 28, 2021
Clovis Oncology CEO Patrick Mahaffy's 2019 pay rises 10% to $6.9M
April 24, 2020
Clovis Oncology CEO Patrick Mahaffy's 2018 pay falls 28% to $6.3M
April 26, 2019